Khoja Hamid
SEC insider (Form 3/4/5 filer). CIK 0002010662. Chief Scientific Officer at FibroBiologics, Inc. (FBLG). 6 reported Form 4/5 transactions since Sep 2024; latest on Sep 15, 2026. Located in HOUSTON, TX.
Companies Khoja Hamid has filed insider reports for
- FibroBiologics, Inc. (FBLG): Officer, Chief Scientific Officer
Khoja Hamid
CIK: 0002010662
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FibroBiologics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Sep 15, 2026FBLG
FibroBiologics, Inc.
AwardDirect298.5K shares at avg. $1.68$500K - May 4, 2026FBLG
FibroBiologics, Inc.
AwardDirectStock Option (Right to Buy)
61.6K shares- - Mar 4, 2026FBLG
FibroBiologics, Inc.
PurchaseDirect30K shares at avg. $0.38$11K - May 27, 2025FBLG
FibroBiologics, Inc.
PurchaseDirect20K shares at avg. $0.84$17K - Mar 26, 2025FBLG
FibroBiologics, Inc.
AwardDirectStock Option (Right to Buy)
189K shares- - Dec 27, 2024FBLG
FibroBiologics, Inc.
AwardDirectStock Option (Right to Buy)
176.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 | FBLG FibroBiologics, Inc. | Award | 298,508 | $1.68 | $500,001 | Direct |
| May 4, 2026 | FBLG FibroBiologics, Inc. | Award Stock Option (Right to Buy) | 61,607 | - | - | Direct |
| Mar 4, 2026 | FBLG FibroBiologics, Inc. | Purchase | 30,000 | $0.38 | $11,400 | Direct |
| May 27, 2025 | FBLG FibroBiologics, Inc. | Purchase | 20,000 | $0.84 | $16,800 | Direct |
| Mar 26, 2025 | FBLG FibroBiologics, Inc. | Award Stock Option (Right to Buy) | 189,000 | - | - | Direct |
| Dec 27, 2024 | FBLG FibroBiologics, Inc. | Award Stock Option (Right to Buy) | 176,200 | - | - | Direct |
1-6 of 6 transactions